Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-07-020218
Filing Date
2007-03-19
Accepted
2007-03-19 21:29:31
Documents
1
Period of Report
2007-03-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 OF JOSEPH C. MCNAY (MARCH 15, 2007) rrd151707.html 4  
1 FORM 4 OF JOSEPH C. MCNAY (MARCH 15, 2007) rrd151707.xml 4 16720
  Complete submission text file 0001181431-07-020218.txt   18682
Mailing Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 3019611992
REGENERX BIOPHARMACEUTICALS INC (Issuer) CIK: 0000707511 (see all company filings)

EIN.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3 BETHESDA METRO CENTER STE 700 C/O REGENERX BIOPHARMACEUTICALS INC BETHESDA MD 20814
Business Address
MCNAY JOSEPH C (Reporting) CIK: 0001257674 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-15070 | Film No.: 07704973